Thomas F. Dejgaard

Thomas Dejgaard

MD, PhD-student
Steno Clinic AND Department of Endocrinology Hvidovre Hospital.

E-mail thomas.fremming.dejgaard@regionh.dk
Phone +45 30 91 29 67

 

Research area
Areas of special interest:
- Incretin hormones
- Type 1 Diabetes, pathophysiology and novel treatments
- Insulin sensitivity
- Inactivity

On-going projects
NewLira
The Lira and Pump Trial 
EASE 2
MAG 1C trial
Alfa-1 trial
Pre-D trial

Education
2009 MD, University of Copenhagen.

Positions
PhD-student at Steno Diabetes Center and Dep. Of Endocrinology Hvidovre Hospital (2012- ).

Introduction in Internal Medicine Department of Endocrinology and Cardiology Hvidovre Hospital (2012).

Department of Internal Medicine O Herlev Hospital (2011-12).

Introduction in Internal Medicin at department of Endocrinology Herlev Hospital (2010-11).

Internship at Department of Orthopaedics Herlev Hospital and General Medicine, StoreHus lægerne (2009-10).

Scholarship at Center for Inflammation and Metabolisme, Rigshospitalet (2008-09).   

Presentations the last 3 years
2016 ECE invited speaker “GLP-1 in type 1 diabetic patients”
2016 Danish Endocrine Society “GLP-1 in type 1 diabetes - effects on glycaemic recovery, gastric emptying and counterregulatory hormones during hypoglycaemia.

2015 EASD “The Lira-1 study”

2015 ADA “Liraglutide for the Treatment of Type 1 Diabetes”

2015 Danish Endocrine Society “GLP-1 and Type 1 Diabetes”

2014 EASD “Autonomic dysfunction is associated with loss of postprandial glycaemic control in newly diagnosed type 2 diabetes patients”

Publications

Levels of the inflammation marker YKL-40 in young adults exposed to intrauterine hyperglycemia.
Kelstrup L, Dejgaard TF, Clausen TD, Mathiesen ER, Hansen T, Vestergaard H, Damm P.
Diabetes Res Clin Pract. 2016 Apr;114:50-4. doi: 10.1016/j.diabres.2016.01.004. Epub 2016 Jan 12.

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Frandsen CS, Dejgaard TF, Madsbad S.
Lancet Diabetes Endocrinol. 2016 Mar 8. pii: S2213-8587(16)00039-5. doi: 10.1016/S2213-8587(16)00039-5. [Epub ahead of print] Review.

Liraglutide for treating type 1 diabetes.
Dejgaard TF, Frandsen CS, Holst JJ, Madsbad S.
Expert Opin Biol Ther. 2016 Apr;16(4):579-90. doi: 10.1517/14712598.2016.1160050.

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF, Frandsen CS, Hansen TS, Almdal T, Urhammer S, Pedersen-Bjergaard U, Jensen T, Jensen AK, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU.
Lancet Diabetes Endocrinol. 2016 Mar;4(3):221-32. doi: 10.1016/S2213-8587(15)00436-2. Epub 2015 Dec 3.

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Frandsen CS, Dejgaard TF, Holst JJ, Andersen HU, Thorsteinsson B, Madsbad S.
Diabetes Care. 2015 Dec;38(12):2250-7. doi: 10.2337/dc15-1037. Epub 2015 Oct 20.

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
Dejgaard TF, Knop FK, Tarnow L, Frandsen CS, Hansen TS, Almdal T, Holst JJ, Madsbad S, Andersen HU.
BMJ Open. 2015 Apr 2;5(4):e007791. doi: 10.1136/bmjopen-2015-007791.

Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy.
Hvid T, Winding K, Rinnov A, Dejgaard T, Thomsen C, Iversen P, Brasso K, Mikines KJ, van Hall G, Lindegaard B, Solomon TP, Pedersen BK.
1. Endocr Relat Cancer. 2013 Aug 19;20(5):621-32. doi: 10.1530/ERC-12-0393. Print 2013 Oct.

Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men.
Knudsen SH, Hansen LS, Pedersen M, Dejgaard T, Hansen J, Hall GV, Thomsen C, Solomon TP, Pedersen BK, Krogh-Madsen R.
2. J Appl Physiol (1985). 2012 Jul;113(1):7-15. doi: 10.1152/japplphysiol.00189.2011. Epub 2012 May 3. Erratum in: J Appl Physiol (1985). 2015 Feb 15;118(4):504.

Sidst opdateret 12-01-2017